The invention is directed to physiologically active compounds of the general
formula (Ix)
##STR1##
and compositions containing such compounds, and their prodrugs, and pharmaceutically
acceptable salts and solvates of such compounds and their prodrugs, as well as
to novel compounds within the scope of formula (Ix), and to processes for their
preparation. Such compounds and compositions have valuable pharmaceutical properties,
in particular the ability to inhibit kinases.
